CD13hi Neutrophil-like myeloid-derived suppressor cells exert immune suppression through Arginase 1 expression in pancreatic ductal adenocarcinoma-Reference-Cited by-同舟云学术

CD13hi Neutrophil-like myeloid-derived suppressor cells exert immune suppression through Arginase 1 expression in pancreatic ductal adenocarcinoma

Published:2017-02 Issue:2 Volume:6 Page:e1258504
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Zhang Jing¹,Xu Xiongfei²,Shi Min¹,Chen Ying¹,Yu Danghui¹,Zhao Chenyan¹,Gu Yan³,Yang Biao⁴,Guo Shiwei⁴,Ding Guiling¹^ORCID,Jin Gang⁴,Wu Chin-Lee⁵,Zhu Minghua¹

Affiliation:

1. Department of Pathology, Changhai Hospital, Second Military Medical University, Shanghai, China

2. Department of Pathophysiology, Second Military Medical University, Shanghai, China

3. National Key Laboratory of Medical Immunology & Institute of Immunology, Second Military Medical University, Shanghai, China

4. Department of General Surgery, Changhai Hospital, Second Military Medical University, Shanghai, China

5. Department of Pathology, Massachusetts General Hospital, Harvard Medical University, Boston, MA, USA

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2016.1258504

Reference32 articles.

1. Myeloid‐derived suppressor cells in cancer: recent progress and prospects

2. Coordinated regulation of myeloid cells by tumours

3. Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer

4. Myeloid-derived suppressor cell heterogeneity in human cancers

5. Myeloid derived suppressor cells in human diseases

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting amino acid-metabolizing enzymes for cancer immunotherapy;Frontiers in Immunology;2024-08-14

2. Current and future immunotherapeutic approaches in pancreatic cancer treatment;Journal of Hematology & Oncology;2024-06-04

3. Myeloid-derived suppressor cells in cancer: therapeutic targets to overcome tumor immune evasion;Experimental Hematology & Oncology;2024-04-12

4. Tumour‐associated neutrophils: Potential therapeutic targets in pancreatic cancer immunotherapy;Immunology;2024-02-25

5. Surface CD52, CD84, and PTGER2 mark mature PMN-MDSCs from cancer patients and G-CSF-treated donors;Cell Reports Medicine;2024-02